It was proven that the loss of Smad3 can work in tandem with a loss of p27KIP1, which is also frequently altered in human T-cell ALL, to promote T-cell leukemogenesis in mice[250]. Here, SMAD3 is linked to T-cell acute lymphoblastic leukemia.